About Macular Degeneration
Living and Thriving
Resources
Our Grants
Caregiver’s Corner
News
About Us
Contact
Store
Get Involved
Go Back
Living and Thriving
Low Vision Resources
Emotional Well Being
AMD Diet and Nutrition
Legal and Benefits
Go Back
Low Vision Resources
Low Vision Rehabilitation
AMD Living Video Series
Assistive Technology for Age-related Macular Degeneration
Go Back
Our Grants
Our Grants Program
Research into Age-related Macular Degeneration

Search results for: “Macular degeneration”

  • AMD Living: Telling Time with Low Vision

    There are many low vision options to tell time with macular degeneration. In this short video, Beth Daisy demonstrates some of those options. Beth Daisy is a low vision occupational therapist at Future in Sight. This video was made possible by The Palmina Gioioso Fund, in honor of her memory.

    Continue Reading

  • AMD Living: Smart Device Accessibility

    Learn how to access and adjust your accessibility settings on your phone or tablet for macular degeneration low vision. While technology changes this video should still point you in the right direction to find your devices’ low vision accessibility features so you can adjust contrast, magnification, and more to suit your low vision needs. This…

    Continue Reading

  • Low Vision Rehabilitation

    Low Vision Rehabilitation

    One of the most important, but under-utilized, services available for people with vision loss from macular degeneration is Low Vision Rehabilitation. Many people think they need to accept their vision loss and the subsequent losses of favorite activities and independence, leading to lower quality of life, grief, and depression1. This does not have to be…

    Continue Reading

  • Write Your Representatives

    ACTION DATES: Feb 25-29, 2024 ** This action has passed. The letter and form will be updated as we approach Access in Sight Week 2025. Check back in early 2025. Let’s mobilize to ask Washington for better access for all Americans with macular degeneration and low vision! Fill out the form letter below with your…

    Continue Reading

  • Access in Sight Call Script

    **The call script below is for 2024 advocacy efforts and was last updated on Feb 21, 2024. This will be updated as we get closer to Access in Sight 2025. You may want to print this out and add your information (including a little bit about how AMD affects you). To find the phone numbers…

    Continue Reading

  • Access in Sight! AMD Advocacy and Action Week

    AMDF has declared the fourth week of February as Access in Sight! AMD/Low Vision Advocacy and Action Week, as part of the annual Age-related Macular Degeneration (AMD) and Low Vision Awareness Month every February. 2025 DATES: February 23-28 Access in Sight!  AMD Advocacy and Action Week is a public call-to-action to bring the attention of…

    Continue Reading

  • 2025 AMD and Low Vision Awareness Month Resources

    AMD Awareness Month, sometimes also referred to as AMD and Low Vision Awareness Month, was established in 2008 to raise awareness about the national prevalence and impact of age-related macular degeneration (AMD) on individuals, and the rippling effect on their networks of care. In 2025, the state of AMD in the United States remains alarming.…

    Continue Reading

  • Advocacy for a Cure: How AMDF is Making a Difference in Washington DC

    September 2023  The American Macular Degeneration Foundation participated in Capitol Hill events hosted by the Alliance for Eye and Vision Research (AEVR) for the 5th year in a row. The purpose of these events is to raise awareness about the need for increased eye research funding to keep pace with the cost of meaningful eye…

    Continue Reading

  • Safety Information for SYFOVRE to Treat Geographic Atrophy

    Important Safety Information The following summary of safety information about SYFOVRE™ is from Apellis Pharmaceuticals, Inc. at https://syfovre.com Please visit their website for full information. The following information is for education only, and does not constitute medical advice. It is important to consult with your eye care specialist(s) to determine if SYFOVRE™ is right for…

    Continue Reading

  • Breaking News – FDA Approves First Geographic Atrophy Treatment, SYFOVRE

    A groundbreaking, new frontier in macular degeneration treatment has been announced! With the FDA’s approval of Syfovre™, for the first time there’s hope to preserve sight for millions of patients with the advanced stage of dry macular degeneration (dry AMD), called geographic atrophy (GA). “This is extraordinary news,” said Chip Goehring, Founder and President of…

    Continue Reading